Work

66P Camrelizumab combined with paclitaxel and nedaplatin in the first-line treatment of locally advanced/advanced esophageal squamous cell carcinoma: A phase II, single-arm, exploratory research

Year: 2021

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2021.10.084

Authors: X. Wang, J. Ma, J. Zhang, Y. Yang, D. Zheng, H. Liang, L. Zhang, Y. Xin, X. Ling, C. Fang, H. Jiang, W. Zheng

Institution: Third Affiliated Hospital of Harbin Medical University

Language: English

Topic: Esophageal Cancer Research and Treatment

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4200141013

FWCI:

Cites:

Cited by:

Related to: 10